CompanyHeadquarters:
Cambridge, MAAlnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.Subsidiaries:
Regulus Therapeutics Inc., Alnylam Europe AG, MORECEO:
John MaraganoreEmployees number:
> 500 (2017)